Table 3.
Variable | Univariable Logistic Regression | Multivariable Logistic Regression | ||
---|---|---|---|---|
OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
LVEDV (per 5 mL) | 0.98 (0.94–1.03) | 0.422 | 1.01 (0.96–1.06) | 0.817 |
LVESV (per 5 mL) | 0.99 (0.93–1.06) | 0.844 | 1.03 (0.95–1.11) | 0.493 |
LVEF (per 5%) | 1.01 (0.75–1.35) | 0.957 | 0.90 (0.65–1.25) | 0.525 |
RVEDV (per 5 mL) | 0.98 (0.93–1.04) | 0.491 | 1.02 (0.96–1.09) | 0.519 |
RVESV (per 5 mL) | 0.99 (0.89–1.10) | 0.823 | 1.07 (0.94–1.21) | 0.309 |
RVEF (per 5%) | 0.97 (0.66–1.44) | 0.899 | 0.79 (0.49–1.28) | 0.337 |
T2 signal ratio | 0.87 (0.28–2.65) | 0.801 | 0.60 (0.16–2.16) | 0.433 |
EGE (%) | 0.98 (0.86–1.11) | 0.766 | 0.95 (0.83–1.09) | 0.474 |
LGE (%) | 0.93 (0.83–1.05) | 0.27 | 0.93 (0.81–1.06) | 0.254 |
Native T1-mapping (per 10 ms) | 1.01 (0.95–1.09) | 0.702 | 0.94 (0.86–1.02) | 0.169 |
Post-contrast T1-mapping (per 10 ms) | 0.93 (0.85–1.03) | 0.168 | 0.94 (0.85–1.05) | 0.283 |
ECV (%) | 1.11 (0.98–1.27) | 0.103 | 1.08 (0.96–1.21) | 0.197 |
T2-mapping (ms) | 1.02 (0.95–1.10) | 0.53 | 0.98 (0.90–1.06) | 0.563 |
ARD patients (compared with controls) | 9.10 (2.84–29.17) | <0.001 * | 6.26 (1.74–22.49) | 0.005 * |
ARD autoimmune rheumatic disease; LV-/RV left/right ventricular; EDV/ESV end-diastolic/-systolic volume; EF ejection fraction; EGE/LGE early/late gadolinium enhancement; ECV extracellular volume fraction. * p ≤ 0.05.